These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 26569432)
1. Dendritic cells in brain diseases. Ludewig P; Gallizioli M; Urra X; Behr S; Brait VH; Gelderblom M; Magnus T; Planas AM Biochim Biophys Acta; 2016 Mar; 1862(3):352-67. PubMed ID: 26569432 [No Abstract] [Full Text] [Related]
2. MRI of animal models of brain disease. van der Weerd L; Thomas DL; Thornton JS; Lythgoe MF Methods Enzymol; 2004; 386():149-77. PubMed ID: 15120250 [No Abstract] [Full Text] [Related]
3. Myeloid derived suppressor cells in inflammatory conditions of the central nervous system. Melero-Jerez C; Ortega MC; Moliné-Velázquez V; Clemente D Biochim Biophys Acta; 2016 Mar; 1862(3):368-80. PubMed ID: 26527182 [TBL] [Abstract][Full Text] [Related]
4. Stop inflammation and you stop neurodegeneration in MS - YES. Yong HY; Yong VW Mult Scler; 2017 Sep; 23(10):1320-1321. PubMed ID: 28463075 [No Abstract] [Full Text] [Related]
5. Stop inflammation and you stop neurodegeneration in MS - NO. Kalincik T Mult Scler; 2017 Sep; 23(10):1321-1323. PubMed ID: 28463073 [No Abstract] [Full Text] [Related]
7. CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression. Clarkson BD; Walker A; Harris MG; Rayasam A; Sandor M; Fabry Z J Immunol; 2015 Jan; 194(2):531-41. PubMed ID: 25505278 [TBL] [Abstract][Full Text] [Related]
8. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke. Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183 [TBL] [Abstract][Full Text] [Related]
9. The role of dendritic cells in neurodegenerative diseases. Iribarren P; Cui YH; Le Y; Wang JM Arch Immunol Ther Exp (Warsz); 2002; 50(3):187-96. PubMed ID: 12098934 [TBL] [Abstract][Full Text] [Related]
14. Targeting neuro-immune communication in neurodegeneration: Challenges and opportunities. Deczkowska A; Schwartz M J Exp Med; 2018 Nov; 215(11):2702-2704. PubMed ID: 30301785 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide plays a key role in the suppressive activity of tolerogenic dendritic cells. Verinaud L; Issayama LK; Zanucoli F; de Carvalho AC; da Costa TA; Di Gangi R; Bonfanti AP; Ferreira IT; de Oliveira AL; Machado DR; Thomé R Cell Mol Immunol; 2015 May; 12(3):384-6. PubMed ID: 25308751 [No Abstract] [Full Text] [Related]
16. Dendritic cells in inflammatory responses in the CNS. Matyszak MK; Perry VH Adv Exp Med Biol; 1997; 417():295-9. PubMed ID: 9286376 [No Abstract] [Full Text] [Related]
17. New developments in understanding and treating neuroinflammation. Infante-Duarte C; Waiczies S; Wuerfel J; Zipp F J Mol Med (Berl); 2008 Sep; 86(9):975-85. PubMed ID: 18196212 [TBL] [Abstract][Full Text] [Related]